About Innoventric
Innoventric is a company based in Ness Ziona (Israel) founded in 2017 by Rafi Benary. Innoventric has raised $41.81 million across 4 funding rounds from investors including RA Capital, European Union and Mivtach Shamir Holdings. Innoventric offers products and services including Trillium, Unica, and Koala. Innoventric operates in a competitive market with competitors including TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Saranas, among others.
- Headquarter Ness Ziona, Israel
- Founders Rafi Benary
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Innoventric Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$41.81 M (USD)
in 4 rounds
-
Latest Funding Round
$28.5 M (USD), Series B
Oct 29, 2024
-
Investors
RA Capital
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Innoventric
Innoventric offers a comprehensive portfolio of products and services, including Trillium, Unica, and Koala.
Device for quick TR treatment with hemodynamic improvements.
Heterotopic solution for TR patients via cross-caval technology.
Supportive device for TR management in clinical settings.
People of Innoventric
Unlock access to complete
Funding Insights of Innoventric
Innoventric has successfully raised a total of $41.81M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $28.5 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Innoventric
Innoventric has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include RA Capital, European Union and Mivtach Shamir Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and technology solutions are provided by BRM Group.
|
Locked | Locked | Locked | |
|
Private fund focused on debt and equity investments in real estate, tech, energy, and multiple sectors
|
Locked | Locked | Locked | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked |
Investor details for Innoventric
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Innoventric
Investment portfolio details for Innoventric
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Innoventric
Detailed financials for Innoventric
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Innoventric Comparisons
Peer comparison for Innoventric
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Innoventric
Innoventric operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Saranas, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| Locked | Locked | Locked |
AV fistula maturation and patency are supported by VasQ device.
|
|
| Locked | Locked | Locked |
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
|
| Locked | Locked | Locked |
A device for vascular access management is developed.
|
|
| Locked | Locked | Locked |
A device is developed for detecting internal bleeding during catheterization.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
Detailed competitors of Innoventric
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Innoventric
Complete news archive for Innoventric
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Innoventric
Innoventric was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Innoventric is headquartered in Ness Ziona, Israel. It is registered at Ness Ziona, Central District, Israel.
Innoventric is a funded company, having raised a total of $41.81M across 4 funding rounds to date.
Founded in 2017 in Ness Ziona, Israel, transcatheter solutions are developed for patients with heart diseases. Focus is placed on percutaneous devices, including the Trillium, which addresses tricuspid regurgitation through minimally invasive procedures. Operations occur within the medical device sector, emphasizing cardiovascular treatments. Geography is centered in Israel, with activities aimed at advancing interventional cardiology options for clinical use.
Innoventric's top competitors include TISSIUM, Vivasure Medical and Cardival Medical.
Innoventric offers Trillium, Unica, and Koala.
Innoventric has 6 investors. Key investors include RA Capital, European Union, Mivtach Shamir Holdings, BRM, and JG Investment.